Lv1
48 积分 2025-03-25 加入
CAR T-cell therapies in China: rapid evolution and a bright future
13天前
已完结
Cytokine Storm
14天前
已完结
Reprogramming of urea cycle in cancer: Mechanism, regulation and prospective therapeutic scopes
28天前
已完结
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
29天前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
1个月前
已完结
Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer
1个月前
已完结
Construction of Artificial Cells with Urea Cycle Pathway for Ammonia Detoxification
1个月前
已完结
Metabolic modulation of tumours with engineered bacteria for immunotherapy
1个月前
已完结
Targeting immune cell metabolism in kidney diseases
1个月前
已完结
Checkpoint inhibitor immunotherapy in kidney cancer
1个月前
已完结
皖公网安备34019202002308
